Memory B cells and long-lived plasma cells in AMR.

Area of Science:

• Nephrology
• Immunology
• Transplantation Science

Background:

• Antibody-mediated rejection (AMR) significantly reduces long-term kidney transplant success.
• Effective treatments for chronic AMR are currently lacking.
• Donor-specific antibodies (DSAs) are key biomarkers for AMR, but their detection may occur after graft damage.

Purpose of the Study:

• To review the production pathways of memory B cells and long-lived plasma cells.
• To propose strategies for preventing DSA production and subsequent AMR.

Main Methods:

• Literature review focusing on B cell and plasma cell biology in transplantation.
• Analysis of mechanisms underlying DSA formation and graft injury.
• Synthesis of current knowledge on AMR pathogenesis.

Main Results:

• Memory B cells and long-lived plasma cells are critical sources of DSAs.
• Early monitoring and intervention targeting these cell populations are crucial.
• Understanding cellular pathways can inform novel preventative strategies.

Conclusions:

• Targeting memory B cells and long-lived plasma cells offers a promising approach to prevent AMR.
• Proactive monitoring and intervention are essential for improving renal allograft survival.
• Further research into these cellular mechanisms can lead to improved post-transplant care.